Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Non Operating Income (2016 - 2025)

Marimed (MRMD) has disclosed Non Operating Income for 10 consecutive years, with -$3.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 206.54% to -$3.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.2 million, a 172.21% decrease, with the full-year FY2024 number at -$50000.0, up 96.94% from a year prior.
  • Non Operating Income was -$3.5 million for Q3 2025 at Marimed, down from $17000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $7.3 million in Q4 2023 to a low of -$3.5 million in Q3 2025.
  • A 5-year average of -$385111.1 and a median of -$663500.0 in 2021 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 1726.25% in 2023; the steepest drop was 488.03% in 2023.
  • Marimed's Non Operating Income stood at $1.8 million in 2021, then plummeted by 77.92% to $400000.0 in 2022, then soared by 1726.25% to $7.3 million in 2023, then crashed by 54.8% to $3.3 million in 2024, then plummeted by 206.54% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Non Operating Income are -$3.5 million (Q3 2025), $17000.0 (Q2 2025), and -$1.7 million (Q1 2025).